Cartilage Repair Market by Modality, Type, Application, and End User - Global Opportunity Analysis and Industry Forecast, 2018-2025

  • ID: 4580660
  • Report
  • Region: Global
  • 240 pages
  • Allied Analytics LLP
1 of 4
Articular cartilage is a complex tissue, which is devoid of blood supply (avascular). It is composed of distinct cells called chondrocytes suspended in a collagenous matrix. The key function of this tissue is to smoothen bone movements, and absorbs shock along with providing cushioning to the joints.

Cartilage repair is a type of cartilage restoration method, wherein the injured cartilage is healed by replacing it with extracellular matrix and new cells. The global cartilage repair market was valued at $713 million in 2017, and is estimated to reach at $2,195 million by 2025, registering a CAGR of 15.0% from 2018 to 2025.

Upsurge in geriatric population, surge in prevalence of degenerative conditions such as osteoarthritis, and rise in sports-related injuries are the key factors that augment the growth of the global cartilage repair market. Furthermore, increase in obesity among the population is expected to boost the market growth.

However, high costs associated with cartilage repair products and an unclear regulatory scenario are some of the factors that impede the market growth. Conversely, high potential of emerging economies and increase in demand for cartilage repair products are expected to provide new opportunities for the market players in future.

The cartilage repair market is segmented based on modality, type, application, end user, and region. On the basis of modality, the market is divided into chondroplasty & microfracture, autologous chondrocyte implantation, osteochondral allograft and juvenile allograft fragments.

By type, it is bifurcated into hyaline cartilage and fibrocartilage. According to application, it is fragmented into knee, shoulder, and others. Depending on end user, it is categorized into hospitals & clinics, ambulatory surgical centers, and others. Region wise, it is analyzed across the North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

This report entails a detailed quantitative analysis of the current market trends from 2017 to 2025 to identify the prevailing opportunities along with strategic assessment of global cartilage repair market.
Market size and estimations are based on comprehensive analysis of the modalities, applications, end users, and developments in the industry.
An in-depth analysis based on region assists to understand the regional market and facilitate the strategic business planning.
The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

KEY MARKET SEGMENTS

By Modality

Chondroplasty & Microfracture
Autologous Chondrocyte Implantation
Osteochondral Allograft
Juvenile Allograft Fragments

By Type

Hyaline Cartilage
Fibrocartilage

By Application

Knee
Shoulder
Others

By End User

Hospitals & Clinics
Ambulatory Surgical Centers
Others

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Taiwan
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

The list of key players operating in this market includes:

Arthrex, Inc.
B. Braun Melsungen AG
Conmed Corporation
Johnson & Johnson
Osiris Therapeutics, Inc.
RTI Surgical, Inc.
Smith & Nephew PLC
Stryker Corporation
Vericel Corporation
Zimmer Biomet Holdings, Inc.

The other players included in the value chain analysis (and not included in the report) include:

Anika Therapeutics, Inc.
Collagen Solutions LLP
Histogenics Corporation
READ MORE
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.1.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Top Player Positioning, 2017
3.4. Patent analysis, 2014-2017
3.4.1. Patent analysis, by year (2014-2017)
3.4.2. Patent analysis, by country
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Surge in obesity in the population
3.5.1.2. Rise in sports-related injuries
3.5.1.3. Rapid increase in geriatric population
3.5.2. Restraints
3.5.2.1. High costs associated with cartilage repair procedures
3.5.2.2. Unclear regulatory scenario
3.5.3. Opportunity
3.5.3.1. Untapped potential of the emerging economies

CHAPTER 4: CARTILAGE REPAIR MARKET, BY MODALITY
4.1. Overview
4.1.1. Market size and forecast
4.2. Microfracture & chondroplasty
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Autologous chondrocyte implantation
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Osteochondral Allograft
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Juvenile Allograft Fragment
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country

CHAPTER 5: CARTILAGE REPAIR MARKET, BY TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Hyaline cartilage
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Fibrocartilage
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country

CHAPTER 6: CARTILAGE REPAIR MARKET BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Knee
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Shoulder
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Others
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country

CHAPTER 7: CARTILAGE REPAIR MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Hospital & clinic
7.2.1. Market size and forecast, by region
7.2.2. Market analysis, by country
7.3. Ambulatory surgical center (ASC)
7.3.1. Market size and forecast, by region
7.3.2. Market analysis, by country
7.4. Others
7.4.1. Market size and forecast, by region
7.4.2. Market analysis, by country

CHAPTER 8: CARTILAGE REPAIR MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast
8.2. North America
8.2.1. Key market trends, growth factors, and opportunities
8.2.2. North America cartilage repair market size and forecast, by country
8.2.2.1. U.S. market size and forecast
8.2.2.1.1. U.S. cartilage repair market, by modality
8.2.2.1.2. U.S. cartilage repair market, by type
8.2.2.1.3. U.S. cartilage repair market, by application
8.2.2.1.4. U.S. cartilage repair market, by end user
8.2.2.2. Canada market size and forecast
8.2.2.2.1. Canada cartilage repair market, by modality
8.2.2.2.2. Canada cartilage repair market, by type
8.2.2.2.3. Canada cartilage repair market, by application
8.2.2.2.4. Canada cartilage repair market, by end user
8.2.2.3. Mexico market size and forecast
8.2.2.3.1. Mexico cartilage repair market, by modality
8.2.2.3.2. Mexico cartilage repair market, by type
8.2.2.3.3. Mexico cartilage repair market, by application
8.2.2.3.4. Mexico cartilage repair market, by end user
8.2.3. North America cartilage repair market size and forecast, by modality
8.2.4. North America cartilage repair market size and forecast, by type
8.2.5. North America cartilage repair market size and forecast, by application
8.2.6. North America cartilage repair market size and forecast, by end user
8.3. Europe
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Europe cartilage repair market size and forecast, by country
8.3.2.1. Germany market size and forecast
8.3.2.1.1. Germany cartilage repair market, by modality
8.3.2.1.2. Germany. cartilage repair market, by type
8.3.2.1.3. Germany cartilage repair market, by application
8.3.2.1.4. Germany cartilage repair market, by end user
8.3.2.2. France market size and forecast
8.3.2.2.1. France cartilage repair market, by modality
8.3.2.2.2. France cartilage repair market, by type
8.3.2.2.3. France cartilage repair market, by application
8.3.2.2.4. France cartilage repair market, by end user
8.3.2.3. UK market size and forecast
8.3.2.3.1. UK cartilage repair market, by modality
8.3.2.3.2. UK cartilage repair market, by type
8.3.2.3.3. UK cartilage repair market, by application
8.3.2.3.4. UK cartilage repair market, by end user
8.3.2.4. Italy market size and forecast
8.3.2.4.1. Italy cartilage repair market, by modality
8.3.2.4.2. Italy cartilage repair market, by type
8.3.2.4.3. Italy cartilage repair market, by application
8.3.2.4.4. Italy cartilage repair market, by end user
8.3.2.5. Spain market size and forecast
8.3.2.5.1. Spain cartilage repair market, by modality
8.3.2.5.2. Spain. cartilage repair market, by type
8.3.2.5.3. Spain cartilage repair market, by application
8.3.2.5.4. Spain cartilage repair market, by end user
8.3.2.6. Rest of Europe market size and forecast
8.3.2.6.1. Rest of Europe cartilage repair market, by modality
8.3.2.6.2. Rest of Europe cartilage repair market, by type
8.3.2.6.3. Rest of Europe cartilage repair market, by application
8.3.2.6.4. Rest of Europe cartilage repair market, by end user
8.3.3. Europe cartilage repair market size and forecast, by modality
8.3.4. Europe cartilage repair market size and forecast, by type
8.3.5. Europe cartilage repair market size and forecast, by application
8.3.6. Europe cartilage repair market size and forecast, by end user
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Asia-Pacific cartilage repair market size and forecast, by country
8.4.2.1. Japan market size and forecast
8.4.2.1.1. Japan cartilage repair market, by modality
8.4.2.1.2. Japan cartilage repair market, by type
8.4.2.1.3. Japan cartilage repair market, by application
8.4.2.1.4. Japan cartilage repair market, by end user
8.4.2.2. China market size and forecast
8.4.2.2.1. China cartilage repair market, by modality
8.4.2.2.2. China cartilage repair market, by type
8.4.2.2.3. China cartilage repair market, by application
8.4.2.2.4. China cartilage repair market, by end user
8.4.2.3. India market size and forecast
8.4.2.3.1. India cartilage repair market, by modality
8.4.2.3.2. India cartilage repair market, by type
8.4.2.3.3. India cartilage repair market, by application
8.4.2.3.4. India cartilage repair market, by end user
8.4.2.4. Australia market size and forecast
8.4.2.4.1. Australia cartilage repair market, by modality
8.4.2.4.2. Australia cartilage repair market, by type
8.4.2.4.3. Australia cartilage repair market, by application
8.4.2.4.4. Australia cartilage repair market, by end user
8.4.2.5. South Korea market size and forecast
8.4.2.5.1. South Korea cartilage repair market, by modality
8.4.2.5.2. South Korea cartilage repair market, by type
8.4.2.5.3. South Korea cartilage repair market, by application
8.4.2.5.4. South Korea cartilage repair market, by end user
8.4.2.6. Taiwan market size and forecast
8.4.2.6.1. Taiwan cartilage repair market, by modality
8.4.2.6.2. Taiwan cartilage repair market, by type
8.4.2.6.3. Taiwan cartilage repair market, by application
8.4.2.6.4. Taiwan cartilage repair market, by end user
8.4.2.7. Rest of Asia-Pacific market size and forecast
8.4.2.7.1. Rest of Asia-Pacific cartilage repair market, by modality
8.4.2.7.2. Rest of Asia-Pacific cartilage repair market, by type
8.4.2.7.3. Rest of Asia-Pacific cartilage repair market, by application
8.4.2.7.4. Rest of Asia-Pacific cartilage repair market, by end user
8.4.3. Asia-Pacific cartilage repair market size and forecast, by modality
8.4.4. Asia-Pacific cartilage repair market size and forecast, by type
8.4.5. Asia-Pacific cartilage repair market size and forecast, by application
8.4.6. Asia-Pacific cartilage repair market size and forecast, by end user
8.5. LAMEA
8.5.1. Key market trends
8.5.2. LAMEA cartilage repair market size and forecast, by country
8.5.2.1. Brazil market size and forecast
8.5.2.1.1. Brazil cartilage repair market, by modality
8.5.2.1.2. Brazil cartilage repair market, by type
8.5.2.1.3. Brazil cartilage repair market, by application
8.5.2.1.4. Brazil cartilage repair market, by end user
8.5.2.2. Saudi Arabia market size and forecast
8.5.2.2.1. Saudi Arabia cartilage repair market, by modality
8.5.2.2.2. Saudi Arabia. cartilage repair market, by type
8.5.2.2.3. Saudi Arabia cartilage repair market, by application
8.5.2.2.4. Saudi Arabia cartilage repair market, by end user
8.5.2.3. South Africa market size and forecast
8.5.2.3.1. South Africa cartilage repair market, by modality
8.5.2.3.2. South Africa cartilage repair market, by type
8.5.2.3.3. South Africa cartilage repair market, by application
8.5.2.3.4. South Africa cartilage repair market, by end user
8.5.2.4. Rest of LAMEA market size and forecast
8.5.2.4.1. Rest of LAMEA cartilage repair market, by modality
8.5.2.4.2. Rest of LAMEA cartilage repair market, by type
8.5.2.4.3. Rest of LAMEA cartilage repair market, by application
8.5.2.4.4. Rest of LAMEA cartilage repair market, by end user
8.5.3. LAMEA cartilage repair market size and forecast, by modality
8.5.4. LAMEA cartilage repair market size and forecast, by type
8.5.5. LAMEA cartilage repair market size and forecast, by application
8.5.6. LAMEA cartilage repair market size and forecast, by end user

CHAPTER 9: COMPANY PROFILES
9.1. Johnson & Johnson
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Business performance
9.2. B. Braun Melsungen AG
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Business performance
9.3. Smith & Nephew Plc.
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Business performance
9.3.5. Key strategic moves and developments
9.4. Stryker Corporation
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Business performance
9.4.5. Key strategic moves and developments
9.5. Zimmer Biomet Holdings, Inc.
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments
9.6. Conmed Corporation
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Business performance
9.7. Arthrex, Inc.
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.8. RTI Surgical, Inc.
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Business performance
9.9. Vericel Corporation
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance
9.9.5. Key strategic moves and developments
9.10. Osiris Therapeutics, Inc.
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Business performance
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to a new report titled, "Cartilage Repair Market by Modality, Type, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2018-2025, the global market was valued at $713 million in 2017, and is projected to reach $2,195 million by 2025, growing at a CAGR of 15.0% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period.

Cartilage repair is a process that encompasses treatment of the damaged cartilage through different modalities such as chondroplasty, autologous chondrocyte implantation, osteochondral allograft, and juvenile allograft fragments to restore normal functions of the connective tissue.

The cartilage repair market is anticipated to grow considerably in the near future, owing to different factors such as increase in obesity & sedentary lifestyle among the population, rise in elderly population, and upsurge in prevalence of arthritis globally. However, high costs associated with cartilage repair procedures and unclear regulatory scenario are the key factors that are expected to impede the market growth. On the contrary, the emerging markets such as India and China are anticipated to provide lucrative growth opportunities to the market players during the forecast period.

By modality, chondroplasty & microfracture accounted for more than one-fourth share of the global cartilage repair market in 2017. In terms of application, the knee segment garnered nearly half of the market share in 2017, and is projected to exhibit prominent growth rate, owing to surge in prevalence of knee osteoarthritis globally.

Among end users, hospitals & clinics generated the highest revenue in 2017, due to different factors such as availability of different treatment options (chondroplasty, osteochondral autograft transplantation, and others) under one roof, palliative care, and diagnosis. By region, North America was the highest revenue contributor in the global market in 2017.

Key findings of the Cartilage Repair Market:

Hyaline cartilage occupied nearly two-thirds share of in the cartilage repair market in 2017.
Knee application is anticipated to grow with the highest CAGR throughout the forecast period.
North America accounted for more than one-third share of the global cartilage repair market in 2017.
Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.

North America was the leading revenue contributor to the global market in 2017, owing to high adoption rate of cartilage repair products. However, Asia-Pacific is expected to grow at the highest CAGR of 16.5% from 2018 to 2025, due to increase in disposable income; surge in research, development, & innovation activities; and rise in awareness towards cartilage repair products.

The report provides an extensive competitive analysis and profiles of the key market players such as Arthrex, Inc., B. Braun Melsungen AG, Conmed Corporation, Johnson & Johnson, Osiris Therapeutics, Inc., RTI Surgical, Inc., Smith & Nephew PLC, Stryker Corporation, Vericel Corporation, and Zimmer Biomet Holdings, Inc. The other players in the value chain (not included in the report) include Anika Therapeutics, Inc., Collagen Solutions LLP, and Histogenics Corporation.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll